You are here

  • Home
  • Archive
  • Volume 59, Issue Suppl 2
  • P70 Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modelling analysis of its prevention utility

Article info

Article menu

Download PDFPDF

BASL abstracts
Viral hepatitis
P70 Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modelling analysis of its prevention utility
Free

Authors

Citation

Hickman M, Martin N, Vickerman P, et al
P70 Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modelling analysis of its prevention utility
Gut 2010;59:A39.

Publication history

  • First published November 16, 2010.
Online issue publication 
April 18, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.